StockOtters
StockOttersSupply Chain Map

Novo Nordisk A/S

NVO

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
290,403
Cost of Revenue
44,522
Gross Profit
245,881
Gross Margin
84.7%
Operating Income
128,339
Operating Margin
44.2%
Net Income
100,988
Net Margin
34.8%
EPS (Basic)
$22.67
EPS (Diluted)
$22.63
EBITDA
137,376
EBITDA Margin
47.3%

2023

12/31/2023

Revenue
232,261
Cost of Revenue
35,765
Gross Profit
196,496
Gross Margin
84.6%
Operating Income
102,574
Operating Margin
44.2%
Net Income
83,683
Net Margin
36.0%
EPS (Basic)
$18.67
EPS (Diluted)
$18.62
EBITDA
113,331
EBITDA Margin
48.8%

2022

12/31/2022

Revenue
176,954
Cost of Revenue
28,448
Gross Profit
148,506
Gross Margin
83.9%
Operating Income
74,809
Operating Margin
42.3%
Net Income
55,525
Net Margin
31.4%
EPS (Basic)
$12.26
EPS (Diluted)
$12.22
EBITDA
76,412
EBITDA Margin
43.2%

2021

12/31/2021

Revenue
140,800
Cost of Revenue
23,658
Gross Profit
117,142
Gross Margin
83.2%
Operating Income
58,644
Operating Margin
41.7%
Net Income
47,757
Net Margin
33.9%
EPS (Basic)
$10.40
EPS (Diluted)
$10.37
EBITDA
64,826
EBITDA Margin
46.0%

2020

12/31/2020

Revenue
126,946
Cost of Revenue
20,932
Gross Profit
106,014
Gross Margin
83.5%
Operating Income
54,126
Operating Margin
42.6%
Net Income
42,138
Net Margin
33.2%
EPS (Basic)
$9.03
EPS (Diluted)
$9.01
EBITDA
58,565
EBITDA Margin
46.1%